Hazard ratio | 95% CI | P-value | |
---|---|---|---|
Univariate analysis | |||
Age < 65 years old | 0.80 | 0.67 ‒ 0.94 | 0.0072 |
Female | 0.95 | 0.82 ‒ 1.11 | 0.5648 |
Surgery (vs. Chemotherapy) | 0.31 | 0.24 ‒ 0.40 | <0.0001 |
Surgery (vs. BSC) | 0.11 | 0.08 ‒ 0.14 | <0.0001 |
Chemotherapy (vs. BSC) | 0.34 | 0.29 ‒ 0.40 | <0.0001 |
Tumor Location (Head) | 0.77 | 0.66 ‒ 0.91 | 0.0015 |
Group B (2006–2010) | 0.81 | 0.69 ‒ 0.94 | 0.0063 |
Stage I‒III | 0.32 | 0.25 ‒ 0.40 | <0.0001 |
Multivariate analysis | |||
Age < 65 years old | 0.94 | 0.79 ‒ 1.11 | 0.4581 |
Surgery (vs. Chemotherapy) | 0.43 | 0.33 ‒ 0.56 | <0.0001 |
Surgery (vs. BSC) | 0.13 | 0.10 ‒ 0.18 | <0.0001 |
Chemotherapy (vs. BSC) | 0.31 | 0.26 ‒ 0.37 | <0.0001 |
Tumor Location (Head) | 0.83 | 0.71 ‒ 0.98 | 0.0294 |
Group B (2006–2010) | 0.91 | 0.78 ‒ 1.06 | 0.2357 |
Stage I‒III | 0.46 | 0.36 ‒ 0.59 | <0.0001 |